Description
Ac-DNLD-CHO (Ac-Asp-Asn-Leu-Asp-CHO) is a Caspase-3/7 inhibitor (IC50: 9.89, 245 nM respectively; Kiapp: 0.68, 55.7 nM respectively). Ac-DNLD-CHO can be used for research of caspase-mediated apoptosis diseases, such as neurodegenerative disorders and viral infection diseases[1].—–C20H31N5O10—-[1]Yoshimori A, et al. Structural and functional definition of the specificity of a novel caspase-3 inhibitor, Ac-DNLD-CHO. BMC Pharmacol. 2007 Jun 27;7:8.–775289-20-8–501.49—-O=C(N[C@@H](CC(C)C)C(N[C@H](C=O)CC(O)=O)=O)[C@H](CC(N)=O)NC([C@@H](NC(C)=O)CC(O)=O)=O–Infection; Neurological Disease–10 mM in DMSO–Caspase—-Apoptosis–Peptides
